What if the next big decision in building a family involved ranking embryos by predicted intelligence before one is even chosen for transfer? I have been turning that question over in my mind ever since the latest claims from a genetics startup began circulating. The idea sits at the intersection of advanced technology and the most personal choices couples make, and it refuses to stay abstract.
How Ai Scoring Is Changing Embryo Decisions For Couples
A company working in genomic analysis recently introduced a set of models it calls Vitruvian. According to the founder, these tools can evaluate embryos created through IVF and rank them on several traits, including cognitive potential. The headline figure that caught attention is a reported gap of roughly 14 IQ points between the highest and lowest scoring embryos in a group of ten. That number is not a promise of guaranteed results for any individual child. It is an average expected difference derived from statistical models trained on large datasets.
The process itself does not involve editing any DNA. Embryos are already produced in a standard IVF cycle. Genetic material is sequenced, and the model assigns scores based on patterns associated with certain outcomes. Parents then receive rankings that can include predicted height, eye and hair color, and risks related to conditions such as breast cancer, type 2 diabetes, or autism, alongside the intelligence estimate. Choosing the top-ranked embryo rather than an average one is said to deliver about half the full spread, roughly seven points in a batch of ten embryos.
In my view this technology sits in a complicated place. On one hand it offers couples more information than they have ever had access to. On the other it raises practical and ethical questions that feel larger than any single clinic appointment. The models were trained on data from hundreds of thousands of people and validated on tens of thousands of sibling pairs. Yet professional groups have expressed clear caution. One major fertility organization has stated that polygenic embryo screening remains unproven for clinical use at this stage. An advertising review body also questioned whether claims about accurately identifying the highest-IQ embryo could be fully supported by the available evidence.
Understanding The Numbers Behind The Claims
Let’s slow down and look at what the figures actually mean. The reported 14-point spread applies to the difference between the top and bottom embryo in a set of ten. With five embryos the expected gap shrinks to around 11 points. Selecting the highest rather than a random or average embryo is projected to yield roughly half that advantage. Earlier research from several years ago estimated much smaller gains, closer to two or three points for a typical cycle. The newer models claim to capture a larger share of the common genetic variance linked to cognitive ability, somewhere near 60 percent according to company materials.
The intelligence score itself is built on association data and tested against sibling pairs of European ancestry in a large biobank. The outcome measure is a verbal-numerical reasoning test rather than a full clinical IQ assessment. After adjustments for test reliability, the score is said to explain about 19 percent of the variance in latent cognitive ability between siblings. These details matter. They show both the ambition of the work and its current boundaries. Genetic influence on intelligence is real and well documented in twin and family studies, often estimated around 50 percent in adulthood. Environment, nutrition, education, and chance still play substantial roles.
I find it useful to keep the distinction clear. A polygenic score is a statistical prediction based on many small genetic variants. It is not a destiny. Two embryos with different scores can still produce children whose actual abilities overlap widely once life experiences enter the picture. Couples considering this path need to weigh the probabilistic nature of the information against the emotional weight of the decision.
What The Process Looks Like In Practice
For couples already undergoing IVF the additional step is relatively straightforward in logistical terms. After embryos reach a certain stage, a small sample of cells is taken for genetic analysis. The sequencing data is run through the scoring models. Results return as comparative rankings rather than absolute guarantees. Height prediction tends to be more accurate because the genetic architecture is better understood. Cognitive scores carry wider confidence intervals. Color traits and disease risks fall somewhere in between depending on the specific condition.
The company began with consumer genetic testing for adults, including an IQ-related report, before expanding into embryo analysis. Funding has come from well-known venture sources, and the total raised sits in the tens of millions. Marketing has been bold. Campaign materials have highlighted heritability estimates for IQ and height and used direct language about having the best possible baby. Some of those messages prompted public discussion and even advertising reviews that recommended more cautious wording.
From a couple’s perspective the practical questions multiply quickly. How many embryos are available in a given cycle? What weight should be given to cognitive scores versus health risks or simply the viability of each embryo? How do partners navigate disagreements if one prioritizes one trait and the other prioritizes another? These are not abstract policy debates. They land in the middle of already stressful medical processes.
The Science Of Polygenic Scores And Cognitive Ability
Polygenic scores work by adding up the small effects of thousands of genetic variants that have been linked to a trait in large population studies. For height the approach has become quite effective. For educational attainment and cognitive test performance the predictive power has improved steadily but remains far from perfect. Within-family validation, such as testing on siblings, is considered stronger evidence because it helps control for shared environment and population structure.
The latest models reportedly explain a meaningful portion of the genetic variance, yet that still leaves a large residual. Non-genetic factors continue to shape outcomes. Even among identical twins raised together, IQ scores are not identical. The idea that selecting the highest-scoring embryo will reliably produce a child with a 7-point advantage assumes that the predicted difference translates cleanly into real-world performance years later. Real life is messier.
Perhaps the most interesting aspect is how quickly the technical capability has advanced relative to the social conversation. A few years ago the expected gains from this type of screening were estimated to be modest. Now the claimed figures are higher. Whether those claims hold up under broader independent scrutiny will determine how widely the tools are adopted.
Ethical Questions Couples Are Already Asking
When technology offers the ability to rank potential children on intelligence, height, or disease risk, the conversation inevitably turns to values. Some couples see the information as simply another data point that helps them make the best decision with the embryos they have. Others feel uneasy about treating cognitive ability as a selectable trait. The line between reducing serious disease risk and optimizing for non-medical characteristics can feel thin depending on personal beliefs.
Professional medical bodies have urged restraint. They note that the technology is still developing and that clinical benefit has not been firmly established. Advertising claims have faced pushback when they appeared to overstate certainty. These cautions matter because the decisions involved are irreversible in a practical sense. Once an embryo is selected and transferred, the path is set.
I have spoken with people who work in fertility care who describe a wide range of patient reactions. Some arrive already informed and eager for every available piece of data. Others prefer to limit the information to health-related risks and leave the rest alone. There is no single correct response. The important part is that couples have space to discuss their priorities openly before results arrive.
Practical Considerations For Partners Navigating The Choice
If a couple decides to use polygenic scoring, several practical steps can reduce friction. First, talk through priorities before the results come back. Decide in advance how much weight each partner places on cognitive scores versus other factors. Second, treat the numbers as probabilities rather than rankings of human worth. Third, keep the conversation focused on the embryos actually available rather than idealized comparisons with population averages.
Cost is another real factor. IVF itself is expensive. Adding advanced genetic analysis increases the total. Insurance coverage varies widely and often does not extend to elective polygenic screening. Couples need clear information about total expected expense before committing.
Emotional load should not be underestimated either. IVF already involves hope, disappointment, and waiting. Layering trait rankings on top can intensify those feelings. Some clinics recommend counseling support specifically for patients considering these options. That recommendation seems sensible.
- Clarify shared priorities before receiving scores
- View results as probabilistic estimates rather than guarantees
- Balance cognitive predictions against health and viability data
- Account for financial and emotional costs alongside medical ones
- Consider professional counseling if the decision feels heavy
How Heritability Fits Into Everyday Family Life
Heritability estimates for intelligence hover around 50 percent in many studies of adults. That figure means genetic differences explain roughly half the variation in cognitive test scores within a given population under current environmental conditions. It does not mean that half of any individual’s intelligence is fixed by genes at conception. Environment still shapes development in powerful ways. Nutrition in early childhood, quality of schooling, exposure to language, and opportunities for complex problem-solving all matter.
When couples look at embryo scores they are looking at one slice of the total picture. A higher polygenic score may shift the expected range upward, but the actual outcome will still depend on the life that follows. This is why some researchers emphasize that the real-world benefit of selection remains uncertain even when the statistical predictions look solid within the training data.
In my experience conversations about heritability often become polarized quickly. One side stresses the predictive power of genetics. The other side stresses the power of environment and the risks of overinterpreting scores. Both perspectives contain truth. The useful middle ground acknowledges genetic influence without treating it as destiny.
Comparing Traits And What The Models Can And Cannot Do
Not all traits are equal in terms of prediction accuracy. Height benefits from a relatively simple genetic architecture and large training datasets. Disease risks vary by condition. Some common variants are well characterized. Others remain poorly understood. Cognitive ability sits in a middle zone. Progress has been real, yet the remaining unexplained variance is still substantial.
Eye and hair color predictions tend to be more straightforward because a smaller number of genes play large roles. Autism risk scoring is more complex and carries higher uncertainty. Couples reviewing reports need to understand these differences rather than treating every score as equally reliable.
The models do not edit DNA. They only rank existing embryos. That distinction is important. The technology is selection, not modification. Future tools may eventually move further, but current offerings stay within the bounds of choosing among embryos already created.
Regulatory And Professional Pushback
Independent review bodies have examined the marketing claims. One advertising standards group recommended that the company stop implying it can accurately identify the highest-IQ embryo within a multi-embryo group, citing insufficient evidence for that level of certainty. The company has indicated it would appeal the finding. Separately, a leading professional society for reproductive medicine has concluded that polygenic embryo screening should not be used clinically at present because the technology remains nascent and unproven.
These positions create a gap between what companies offer and what many clinicians feel comfortable recommending. Couples who encounter the technology may therefore receive mixed messages depending on which clinic they visit and which advisors they consult. Transparency about the current limits of the evidence becomes essential.
I think the tension is healthy. Innovation often moves faster than consensus. Careful scrutiny helps prevent overclaiming while still allowing promising tools to develop under proper oversight.
Broader Implications For How Couples Think About Parenthood
Beyond the technical details lies a quieter shift in how some people approach the decision to have children. Information that was once unavailable now sits on a report. That availability changes the emotional texture of the process. Some couples feel empowered. Others feel pressure to optimize that previous generations never faced.
There is also the question of equity. Advanced genetic analysis adds cost. Access may remain uneven for the foreseeable future. If the technology eventually delivers measurable advantages, differences in access could compound existing disparities. These are long-term societal issues that individual couples cannot solve, yet they form part of the backdrop against which personal decisions are made.
Perhaps the most interesting aspect is how ordinary the conversation can feel once the novelty wears off. Many couples already discuss preferred traits in a light way when imagining future children. Formalizing those preferences into ranked scores simply makes the process more explicit and data-driven. Whether that explicitness is helpful or unsettling depends heavily on individual values.
Balancing Hope With Realistic Expectations
Any discussion of predicted IQ differences needs grounding in what the numbers actually represent. A seven-point expected advantage is meaningful on a population level. On an individual level it sits within the normal range of variation that already exists between siblings. Environment and experience will continue to shape outcomes more dramatically than most people realize.
Couples who choose to use these tools may find the greatest benefit comes not from chasing the highest possible score but from having clearer information about health-related risks. Cognitive ranking may remain secondary for many. The technology offers options. It does not dictate how those options must be used.
I have found that the healthiest approach is to treat the scores as one input among many. Viability of the embryo, overall health markers, and the couple’s own values still form the core of the decision. Adding more data can help, provided it does not overwhelm the human judgment at the center of the process.
Looking Ahead At The Technology And Its Limits
The field is moving quickly. Models will improve as larger and more diverse datasets become available. Validation across ancestry groups remains an important area for progress because current training data often over-represent certain populations. Predictive accuracy for complex traits will likely continue to rise, though the ceiling is still unknown.
At the same time, social and ethical frameworks will need to keep pace. Clear communication about uncertainty, robust independent evaluation, and open discussion of values will matter as much as technical gains. Couples will benefit most when the information they receive is both accurate and carefully contextualized.
The claim of a 14-point spread between embryos in a typical batch has already sparked strong reactions. Some see it as a natural extension of the desire to give children every possible advantage. Others see risks of new forms of pressure or inequality. Both reactions deserve attention. The technology itself is neither inherently good nor bad. Its impact will depend on how thoughtfully it is integrated into the already complex process of building a family.
For couples currently navigating fertility treatment the practical takeaway is straightforward. Ask detailed questions about what any scoring system can and cannot deliver. Request information on the strength of the evidence for each trait. Discuss priorities with your partner before results arrive. And remember that the goal remains a healthy child and a sustainable family life, not a perfect score on a predictive model.
The conversation around embryo ranking will continue to evolve. New data will refine the models. Professional guidelines may shift. Public attitudes will settle somewhere between enthusiasm and caution. In the meantime individual couples will keep making the best decisions they can with the information available to them. That process has always been imperfect. Adding more precise genetic predictions simply changes the nature of the imperfection rather than removing it.
What remains constant is the desire most people feel to give their children a good start. Technology now offers new tools for acting on that desire. Using those tools wisely requires clear eyes about both their power and their limits. The 14-point figure is attention-grabbing. The quieter work of weighing probabilities, values, and real-world outcomes is where the real decisions still live.
As more clinics and patients encounter these options the collective experience will gradually clarify which claims hold up and which need further refinement. Until then a measured approach serves everyone best. Information is valuable. Certainty remains elusive. Couples who hold both truths at once are likely to navigate the choices with greater clarity and less unnecessary pressure.
The story of polygenic embryo screening is still being written. Each cycle, each ranking report, and each personal decision adds another line. Paying attention to the evidence while staying grounded in the broader realities of parenting offers the most reliable path forward for those who choose to engage with the technology.
